Synchrony Financial (SYF) Earnings Analysis

Synchrony Financial (SYF) beat expectations in FY2026 on revenue of $163.9B versus the $159.9B estimate (+5.0% YoY) and EPS of $4.10. Below is the full Synchrony Financial earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Synchrony Financial (SYF) Earnings Analysis — key stats

Next earnings dateFeb 4, 2025
Latest reported quarterFY2026
Earnings verdictBeat
Revenue$163.9B (vs $159.9B est · +2.5% surprise · +5.0% YoY)
EPS$4.10 (vs $3.78 est · +8.5% surprise · +34.9% YoY)
Share price$449.42 (+0.6%)
Market cap$940.0B

What you'll find

Frequently asked questions

When is Synchrony Financial's next earnings date?
Synchrony Financial's (SYF) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Synchrony Financial (SYF) beat or miss earnings?
In FY2026, Synchrony Financial (SYF) posted beat results — revenue of $163.9B versus the $159.9B estimate (+2.5% surprise) and EPS of $4.10 versus $3.78 expected (+8.5% surprise). Magnisto decodes every Synchrony Financial (SYF) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Synchrony Financial (SYF) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Synchrony Financial (SYF), anchored to the current $449.42 share price, so you can weigh the bull, base and bear cases for Synchrony Financial side by side.
Is Synchrony Financial (SYF) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Synchrony Financial fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.